Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: Eur J Cancer. 2016 Feb 12;56:162–171. doi: 10.1016/j.ejca.2015.12.022

Fig. 3.

Fig. 3

Kaplan–Meier curves of progression-free survival (top) and overall survival (OS, bottom) in the elderly (≥70 years of age) patients treated on a randomized phase III clinical trial comparing nab-paclitaxel/carboplatin (nab-PC) versus solvent-based paclitaxel/carboplatin (sb-PC) in patients with newly diagnosed advanced non-small cell lung cancer. Reprinted with permission from Annals of Oncology 24: 314–321, 2013.